Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Proguanil-d4, 1189805-15-9
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Proguanil-d4 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Proguanil-d4 usage and description
Proguanil D4 is a deuterated form of Proguanil, an antimalarial drug that is used to prevent and treat malaria. It is an oral medication that works by inhibiting the enzyme dihydrofolate reductase, which is essential for the growth and survival of the malaria parasite. This drug is often used in combination with another antimalarial medication, such as atovaquone, to provide a more effective treatment.
Proguanil D4 has a molecular formula of C11H12D4ClN5 and a molecular weight of 248.75 g/mol. It is a white to off-white crystalline powder that is freely soluble in water and methanol. The deuterium labeling in this drug enables more precise analysis in pharmacokinetic studies.
The recommended dosage of Proguanil D4 varies depending on the age and weight of the patient, as well as the severity of the malaria infection. It is typically taken once daily, with or without food, for a period of several weeks. However, it is important to note that this medication is not effective against all strains of malaria and should be used in conjunction with other preventative measures, such as insecticide-treated bed nets and mosquito repellent.
Like all medications, Proguanil D4 may cause side effects such as nausea, vomiting, headache, and dizziness. It is important to discuss any potential risks or concerns with a healthcare provider before starting this medication.
